High level of serum AMBP is associated with poor response to paclitaxel–capecitabine chemotherapy in advanced gastric cancer patients

Title
High level of serum AMBP is associated with poor response to paclitaxel–capecitabine chemotherapy in advanced gastric cancer patients
Authors
Keywords
Advanced gastric cancer, Serum, iTRAQ, AMBP, Chemoresistance
Journal
MEDICAL ONCOLOGY
Volume 30, Issue 4, Pages -
Publisher
Springer Nature
Online
2013-10-17
DOI
10.1007/s12032-013-0748-8

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now